Managing moderate bronchiolitis in young children at home
Descriptive Study of the Initial Management of Young Children With Moderate Acute BRONCHiotitis With Home Hospitalisation
Elsan · NCT06842238
This study is testing whether young children with moderate bronchiolitis can be safely treated at home instead of in the hospital to see if it works well for them.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 40 (estimated) |
| Ages | 2 Months to 2 Years |
| Sex | All |
| Sponsor | Elsan (other) |
| Locations | 1 site (Poitiers) |
| Trial ID | NCT06842238 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on the initial management of young children aged 3 months to 2 years who present with moderate acute bronchiolitis. It evaluates the feasibility and safety of home hospitalization as an alternative to traditional hospitalization, provided that certain clinical criteria are met, such as an SpO2 measurement greater than 92%. The study aims to gather data on the outcomes of children managed at home, thereby providing insights into the effectiveness of this approach during the winter season when bronchiolitis cases peak.
Who should consider this trial
Good fit: Ideal candidates include infants aged over 2 months and up to 2 years with moderate bronchiolitis and an SpO2 level above 92%.
Not a fit: Patients with significant comorbidities or those requiring immediate medical intervention will not benefit from this home management approach.
Why it matters
Potential benefit: If successful, this approach could reduce unnecessary hospitalizations and associated stress for families while ensuring safe management of bronchiolitis.
How similar studies have performed: Previous studies have indicated that home management can be effective for similar conditions, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Any infant with moderate bronchiolitis according to the HAS definition (except for the SpO2 criterion which must be greater than or equal to 92% to avoid the patient being on oxygen therapy upon admission) * Age \> 2 months and ≤ 2 years * Respiratory syndrome for 48 hours * Infant with a first episode of bronchiolitis * Referral of the general practitioner/treating pediatrician for home hospitalisation care * Parents' agreement for the choice of home hospitalisation care * Non-opposition or free and informed consent of both parents to the use of the child's health data Exclusion Criteria: * Patient not receiving health protection * Comorbidities: congenital heart disease with shunt, chronic pulmonary pathology including bronchopulmonary dysplasia, neuromuscular pathology, immune deficiency, multiple disabilities Congenital heart disease * Refusal of one or both parents for the proposed pathway * Doubts about the parents' understanding of the nature of home hospitalisation care * Severe bronchiolitis or with saturation \< 92% * Moderate bronchiolitis but evolving for less than 48 hours * Cases of psychiatric pathologies or depressive syndrome diagnosed in the parents.
Where this trial is running
Poitiers
- Polyclinique de Poitiers - HAD — Poitiers, France (RECRUITING)
Study contacts
- Study coordinator: Khaked Husseini, Dr
- Email: recherche.na@elsan.care
- Phone: 0549422617
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Bronchiolitis, Bronchiolitis Acute